| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.009 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.69 | 0.01 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.01 |